Pulmonary valve replacement in repaired tetralogy of Fallot: Determinants of early postoperative adverse outcomes  by Dos, Laura et al.
C
H
D
Dos et al Congenital Heart DiseasePulmonary valve replacement in repaired tetralogy of Fallot:
Determinants of early postoperative adverse outcomes
Laura Dos, MD,a,c Alexander Dadashev, MD,a David Tanous, MBBS,a Ignacio J. Ferreira-Gonza´lez, MD,d
Kim Haberer,a Samuel C. Siu, MD,a Glen S. Van Arsdell, MD,b Erwin N. Oechslin, MD,a
William G. Williams, MD,b and Candice K. Silversides, MDa
Objective: We sought to examine the frequency of early postoperative complications and preoperative predictors
of prolonged hospitalization in adults with repaired tetralogy of Fallot undergoing pulmonary valve replacement.
Methods: This was a retrospective study of consecutive adult patients undergoing surgical intervention between
1995 and 2006. A multivariate logistic regression model was used to identify determinants of prolonged hospi-
talization.
Results: One hundred sixteen patients (mean age, 36 11 years) underwent 118 pulmonary valve replacements.
Most (95%) operations included additional procedures, such as pulmonary artery/outflow tract reconstruction or
tricuspid valve annuloplasty. The early postoperative mortality (<30 days) was 2.5%. The majority of the patients
(60%) had no postoperative complications. The postoperative adverse events included postoperative arrhythmias
(19%), respiratory complications (13%), reoperation during admission (13%), renal dysfunction (13%), and
myocardial infarction (3%). Postoperative adverse events were associated with prolonged hospitalization (14
 12 vs 7 3 days, P¼ .001). In the multivariate analysis age at reoperation of greater than 45 years (odds ratio,
6.1; 95% confidence interval, 1.6–23.6; P ¼ .009), the number of previous sternotomies (odds ratio, 3.8; 95%
confidence interval, 1.4–10; P ¼ .007), and the need for urgent surgical intervention (odds ratio, 5.7; 95% con-
fidence interval, 1.1–27.8; P ¼ .03) were predictors of prolonged hospitalization.
Conclusion: Pulmonary valve replacement in adults with repaired tetralogy of Fallot has a low mortality risk. The
most common early postoperative complications are arrhythmias and respiratory and renal complications. Al-
though most early postoperative complications do not result in long-term sequelae, they are associated with pro-
longed hospitalization. Patients undergoing urgent interventions, older patients, and those with multiple previous
sternotomies are at the highest risk for prolonged hospitalization.Earn CME credits at
http://cme.ctsnetjournals.org
Tetralogy of Fallot (TOF) is one of the most common forms
of cyanotic congenital heart disease. Intracardiac repair, per-
formed primarily in childhood, has been performed for more
than 50 years, and the current early mortality rate is low.1,2
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doi:10.1016/j.jtcvs.2009.02.042The Journal of Thoracic and CAfter repair, pulmonary regurgitation is common, but com-
plications usually do not occur until adulthood. There is in-
creasing need for pulmonary valve replacement (PVR) in the
adult late after TOF repair.3,4 Although the use of percutane-
ous techniques is emerging for a selected group of pa-
tients,5,6 the current treatment for pulmonary regurgitation
continues to be surgical for the majority of patients.
Postoperative adverse outcomes and risk factors for these
events have been well defined in adults with acquired heart
disease undergoing cardiac surgery,7-9 but these large stud-
ies have typically not included adult patients with congenital
heart defects. The limited data on reoperations in adult pa-
tients with congenital heart disease come from studies with
small number of patients and mixed diagnoses.10-13 With
the growing population of patients surviving with TOF
and requiring PVR, a detailed examine of the postoperative
complications and length of stay14-16 is important to identify
the high-risk patients and develop strategies to improve out-
comes. The primary objectives of this study were (1) to de-
termine the frequency of postoperative adverse events
(PAEs) after PVR in adults with repaired TOF and (2) to
identify preoperative factors associated with both PAEs
and prolonged postoperative length of stay (PLOS).ardiovascular Surgery c Volume 138, Number 3 553
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CI ¼ confidence interval
OR ¼ odds ratio
PAE ¼ postoperative adverse event
PLOS ¼ postoperative length of stay
PVR ¼ pulmonary valve replacement
RVOT ¼ right ventricular outflow tract
TOF ¼ tetralogy of Fallot
MATERIALS AND METHODS
After approval by the institutional research ethics board, 136 consecutive
adult patients (>18 years) who underwent late reoperations (>1 year) after
intracardiac repair of TOF between May 1995 and October 2006 were iden-
tified by using a prospectively maintained cardiovascular surgery database
(Cardiovascular Surgery Database, gwillms@istar.ca) at SickKids (Tor-
onto, Canada). Patients with pulmonary atresia were not included because
of the potentially different surgical risk profile of this population, including
the size and distribution of the pulmonary arteries. Among the remaining
cases, 116 patients undergoing 118 PVRs were identified (One of the
patients required a redo PVR 5 years after the initial operation because
of endocarditis, and another patient required redo PVR and tricuspid annu-
loplasty 8 years after the initial operation because of valve degeneration.)
Demographic data, clinical information, and surgical details were
obtained from the patient’s records. Data abstraction also included preoper-
ative blood work, results of preoperative electrocardiographic analysis,
echocardiographic analysis, cardiopulmonary testing, and cardiac magnetic
resonance imaging studies when available.
PAEs included death, need for reoperation, stroke, myocardial infarc-
tion, renal failure, respiratory complications, and postoperative arrhythmias
(see the Appendix for definitions).14,17
Results are presented as the mean and standard deviation for continuous
variables with normal distribution and as the median and interquartile range
for variables with nonnormal distribution. Comparisons of variables were
made by using the Student’s t test, the c2 test, or the Fisher’s exact test,
as appropriate. Preoperative determinants of prolonged PLOS were identi-
fied by using a multivariate logistic regression model. Variables were
entered in the model based on their clinical plausibility and significant
association with the primary end point in the univariate model (<0.10).
RESULTS
Baseline characteristics of the 116 patients (undergoing
118 procedures) are presented in Table 1. The majority of
patients (58%) had initial palliative procedures, including
Blalock–Taussig shunts (51%), Potts shunts (2%), Water-
ston shunts (4%), or closed Brock valvotomies (3%). The
mean age at the time of the first palliative procedure was 3
 3 years (median, 1.9 years; interquartile range, 1–4 years),
and the mean age at the time of intracardiac repair was 9 6
years (median, 7 years; interquartile range, 5–10 years), with
64% receiving a transannular patch. At the time of reopera-
tion, almost half of the cohort (48%) were taking cardiac
medications (furosemide, 18%; digoxin, 16%; b-blockers,
15%; warfarin, 15%; amiodarone, 13%; angiotensin-con-
verting enzyme inhibitors, 9%; aspirin, 10%; spironolac-
tone, 2%; and angiotensin receptor blockers, 1%).554 The Journal of Thoracic and Cardiovascular SuThe indications for PVR were symptomatic severe pulmo-
nary regurgitation (67%), severe pulmonary regurgitation
with ventricular arrhythmias (9%), severe pulmonary regurgi-
tation with progressive right ventricular dilatation (12%), se-
vere pulmonary stenosis (9%), and others (3%). The mean
age at the time of reoperation was 36  11 years (median,
35 years; interquartile range, 28–43 years). Surgical interven-
tion was performed urgently in 10% of cases. The reasons for
urgent surgical intervention were endocarditis in 3 patients,
sustained ventricular tachycardia in 8 patients, and right heart
TABLE 1. Baseline demographics (n ¼ 118)
Variable
Clinical
Age (y) 36  11
Sex (female) 57 (48%)
Body surface area (m2) 1.8  0.24
Body mass index (kg/m2) 26  5
Any cardiac medication 56 (47%)
Diabetes 5 (4%)
Hypertension 4 (3%)
Dyslipidemia 14 (12%)
Smoker 24 (20%)
No. of previous sternotomies 1.2  0.5
History of arrhythmia 52 (44%)
Supraventricular 35 (30%)
Ventricular 23 (19%)
Admission for CHF 15 (13%)
NYHA functional class>2 23 (20%)
History of syncope 18 (15%)
Baseline oxygen saturation (%) 97  3
Right aortic arch 30 (25%)
Laboratory values
Glomerular filtration rate (mL/min) 110  38
Creatinine (mmol/L) 82  25
Electrocardiographic values
Sinus rhythm 106 (90%)
QRS duration (ms) 170  24
QRS>180 ms 49 (42%)
Echocardiographic values (n ¼ 114)
Left ventricular dysfunction>mild 5 (4%)
Right ventricular dysfunction>mild 69 (59%)
Right ventricular diameter (mm)* 52  8
Right ventricular systolic pressure (mm Hg) 50  19
Pulmonary valve peak gradient (mm Hg) 30  21
Significant pulmonary stenosis (>50 mm Hg) 13 (11%)
Moderate-to-severe pulmonary regurgitation 105 (89%)
Moderate-to-severe tricuspid regurgitation 53 (45%)
Cardiac magnetic resonance values (n ¼ 41)
Right ventricular end-diastolic volume, corrected (mL/m2) 192  49
Right ventricular ejection fraction (%) 37  7
Pulmonary regurgitant fraction (%) 38  12
Cardiopulmonary Exercise test results (n ¼ 74)
MVO2 max (mL $ kg
1 $ min1) 20  6
MVO2 max% predicted 54  14
CHF, Congestive heart failure; NYHA, New York Heart Association; MVO2, maxi-
mum oxygen consumption. *As measured on the apical 4-chamber view (basal seg-
ment).rgery c September 2009
C
H
D
Dos et al Congenital Heart Diseasefailure with recurrent presyncopal spells in 1 patient. There
were no emergency cases. Tissue valves were used in all cases:
Hancock (Medtronic, Inc, Minneapolis, Minn), 84% (n ¼
99); Mosaic (Medtronic, Inc), 8% (n ¼ 9); homografts, 3%
(n¼ 4); Carpentier–Edwards (Baxter Healthcare Corp, Santa
Ana, Calif) 2% (n ¼ 2); and others, 3% (n ¼ 3). The mean
size of the prosthesis was 28.9  1.6 mm (range, 24–33
mm). Most interventions (95%) were more complex than sim-
ple PVR alone. The most common concomitant procedures
were pulmonary artery/right ventricular outflow tract
(RVOT) reconstruction and tricuspid valve annuloplasty.
Eleven patients had concomitant aortic or mitral valve opera-
tions (Table 2). The mean bypass time was 132 52 minutes
(median, 131 minutes; interquartile range, 93–161 minutes).
Of the 61 procedures performed with an aortic crossclamp,
the mean myocardial anoxic time was 30  39 minutes (me-
dian, 11 minutes; interquartile range, 0–51 minutes).
Inotropic support was used immediately after surgical in-
tervention in 24% (n ¼ 28) of patients and was more com-
mon in patients requiring urgent surgical intervention (21%
vs 7%, P ¼ .02). The number of previous sternotomies (1.5
 0.7 vs 1.2 0.41, P¼ .05), prolonged bypass time (175
58 vs 119 43 minutes, P<.001) or clamp time (45 42 vs
26  38 minutes, P ¼ .025), and tricuspid valve surgery
(43% vs 20%, P ¼ .015) were associated with the postop-
erative use of inotropes for more than 48 hours.
Postoperative Adverse Events
There were 3 (2.5%) postoperative deaths, with no clearly
preventable causative factors of death being identified. This
included 2 in-hospital deaths. A 21-year-old woman who un-
derwent elective PVR and pulmonary arterioplasty experi-
enced cardiac arrest 24 hours after intensive care unit
discharge. She underwent a sternotomy during cardiac arrest,
was started on emergency cardiopulmonary bypass, and was
converted to an extracorporeal membrane oxygenation circuit
because of failure to wean from bypass. She had severe biven-
tricular dysfunction and subsequently died of multiorgan fail-
ure 7 days later. She had preoperative normal biventricular
TABLE 2. Types of surgical procedures
Surgical procedure No. (%)
Pulmonary artery arterioplasty 87 (74%)
RVOT aneurysmectomy 50 (42%)
Tricuspid valve annuloplasty 30 (25%)
Atrial ablation 24 (20%)
Ventricular ablation 19 (16%)
PFO/ASD closure 25 (21%)
Residual VSD closure 14 (12%)
AV repair/replacement 4 (3%)
Ascending aorta replacement 4 (3%)
MV repair/replacement 3 (3%)
Others 5 (4%)
RVOT, Right ventricular outflow tract; PFO, patent foramen ovale; ASD, atrial septal
defect; VSD, ventricular septal defect; AV, aortic valve; MV, mitral valve.The Journal of Thoracic andfunction and no history of arrhythmic events. No coronary ar-
tery injury was identified premortem or postmortem, although
a large subacute hemorrhagic myocardial infarction involving
the left ventricle was identified at autopsy. The second in-hos-
pital death was in a 44-year-old man with preoperative New
York Heart Association functional class III and moderate
left ventricular dysfunction. He underwent elective PVR, bi-
lateral pulmonary artery arterioplasties, and patch closure of
a large residual ventricular septal defect. He was unable to
be weaned off bypass because of severe biventricular dys-
function, despite subsequent fenestration of the ventricular
septal defect patch. Information about intraoperative echocar-
diographic results is not available. There was a third death
caused by intracranial hemorrhage 4 days after hospital dis-
charge in a 43-year-old woman undergoing elective PVR
who was taking chronic oral anticoagulation for prior sys-
temic embolism. Heparin and warfarin had been commenced
before hospital discharge, and then warfarin was continued in
conjunction with low-molecular-weight heparin after hospital
discharge. At no time, including at presentation with the cere-
bral bleed, had there been supratherapeutic anticoagulant
levels. Information regarding patient status after discharge
was not available in 4 patients.
Most patients (60%) had no postoperative complications.
The frequencies of adverse events are shown in Figure 1.
The most common PAEs were arrhythmias, respiratory com-
plications, renal dysfunction, and need for reoperation (pri-
marily caused by bleeding). No episodes of stroke were
recorded.
Postoperative arrhythmias. Postoperative arrhythmias
were documented in 23 (20%) patients: 19 supraventricular
arrhythmias, 3 ventricular arrhythmias, and 1 case of com-
bined supraventricular and ventricular arrhythmia. Patients
who had arrhythmias when compared with patients who
did not more commonly had a history of arrhythmia (74%
vs 37%, P ¼ .001), were older at the time of reoperation
(age>45 years: 39% vs 13%, P ¼ .004), and had a longer
bypass time (155  39 vs 126  53 minutes, P ¼ .02).
FIGURE 1. Frequency of postoperative events.Cardiovascular Surgery c Volume 138, Number 3 555
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occurred in 16 (14%) patients, 4 of which were respiratory
infections (2 with Haemophilus influenzae, 1 with Serratia
species, and 1 with combined Klebsiella and Pseudomonas
species) successfully treated with antibiotics. Respiratory
complications were associated with more complex interven-
tions: longer bypass time (179  54 vs 125 48 minutes, P
< .001), increased number of previous sternotomies (1.7 
0.9 vs 1.2  0.4, P ¼ .03), urgent procedures (25% vs
8%, P ¼ .04), and concomitant surgical procedures involv-
ing the tricuspid valve (50% vs 22%, P ¼ .02). In the sub-
group of 74 patients with preoperative cardiopulmonary
studies, none of the quantitative parameters (patients without
vs with respiratory complications: maximum oxygen con-
sumption, 18 vs 20 mL $ kg1 $ min1, P¼ .55; baseline ox-
ygen saturation, 96% vs 97%, P ¼ .06; forced vital
capacity, 3.2 vs 3.23 L, P¼ 0.86; and forced expiratory vol-
ume in 1 second, 2.5 vs 2.7 L, P¼ .74) were associated with
postoperative respiratory complications.
Reoperation. Reoperation during hospitalization was re-
quired in 16 (14%), patients and the most common indica-
tion was surgical bleeding (9%, n ¼ 12). Reoperation for
bleeding was not associated with prolonged hospitalization.
There were no cases of cardiac tamponade. Other reasons for
reoperation included debridement and rewiring of a deep
wound infection (n ¼ 1), initiation of extracorporeal mem-
brane oxygenation (n¼ 1), pacemaker implantation because
of postoperative complete atrioventricular block (n ¼ 1),
and postoperative myocardial infarction caused by compres-
sion of the left anterior descendent coronary artery by one of
the right outflow tract running sutures (n ¼ 1). In this latter556 The Journal of Thoracic and Cardiovascular Sucase the coronary artery was freed at the time of reoperation,
and no bypass grafting was necessary.
Renal dysfunction. Renal dysfunction was documented in
15 (13%) patients, 3 of whom required hemodialysis. Renal
dysfunction was more common in patients undergoing ur-
gent surgical intervention (27% vs 8%, P ¼ .05), patients
undergoing interventions involving the tricuspid valve
(47% vs 22%, P ¼ .04), and those who had prolonged
clamp times (51  30 vs 27  40 minutes, P ¼ .028).
Myocardial infarction. There were 4 (3%) patients with
myocardial infarction. Given the low atherosclerotic risk pro-
file of our population (Table 1), the most plausible mechanism
for these cardiac events were inadvertent surgical injury of the
coronary arteries, especially in the presence of coronary
anomalies,18 which in our series was only demonstrated by
means of postoperative cardiac magnetic resonance in one
of the cases (anomalous coronary artery crossing RVOT).
Prolonged PLOS
The mean in-hospital length of stay was 9  8 days (me-
dian, 7 days; interquartile range, 6–10 days). Patients with
PAEs (excluding death) had a significantly longer mean
PLOS (14  12 vs 7  3 days, P ¼ .001). In 14 patients
(12%) the admission time exceeded 14 days (prolonged
PLOS, as defined). Adverse postoperative events that
were associated with a prolonged PLOS in a univariate
analysis included respiratory complications (50% vs 9%,
P< .001), postoperative arrhythmia (50% vs 16%, P ¼
.003), and acute renal failure (43% vs 8%, P < .001).
Reoperation (21% vs 12%, P ¼ .32) and myocardial in-
farction (7% vs 2%, P ¼ .25) were not associated withTABLE 3. Univariate analysis: Predictors of prolonged postoperative length of stay
Preoperative variable Prolonged PLOS (n ¼ 14) No prolonged PLOS (n ¼ 104) P value
Sex (female) 6 (43%) 51 (49%) .66
BMI (kg/m2) 26  4 26  5 .89
BSA (m2) 1.8  0.2 1.8  0.2 .95
Any CV risk factor* 5 (36%) 36 (35%) .93
History of arrhythmia 9 (64%) 43 (41%) .10
Admission for CHF 3 (21%) 12 (11%) .29
Age at initial repair (y) 11  11 9  6 .19
Age at reoperation>45 y 7 (50%) 15 (14%) .001
No. of previous sternotomies 1.8  0.9 1.2  0.4 .022
Baseline O2 saturation (%) 97  2 97  3 .83
Significant PS (>50 mm Hg) 1 (7%) 12 (12%) .62
TR, moderate to severe 9 (64%) 44 (44%) .14
QRS duration (ms) 181  20 169  25 .07
Urgent operation 5 (36%) 7 (7%) .001
Tricuspid valve surgery 6 (43%) 24 (23%) .11
Arrhythmia surgery 5 (36%) 34 (33%) .82
Bypass time 159  49 128  52 .035
Clamp time (n ¼ 61) 27  33 31  40 .77
PLOS, Postoperative length of stay; BMI, body mass index; BSA, body surface area; CV, cardiovascular; CHF, congestive heart failure; PS, pulmonary stenosis; TR, tricuspid re-
gurgitation. *Includes smoking, diabetes, dyslipidemia, and hypertension.rgery c September 2009
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with PLOS in the univariate analysis are shown in Table
3. In the multivariate model age at reoperation of greater
than 45 years (odds ratio [OR], 6.1; 95% confidence inter-
val [CI], 1.6–23.6; P ¼ .009), the number of previous ster-
notomies (OR, 3.8; 95% CI, 1.4–10; P ¼ .007), and the
need for urgent surgical intervention (OR, 5.7; 95% CI,
1.1–27.8; P ¼ .03) were independently associated with pro-
longed PLOS (Table 4). By using the 3 risk factors identi-
fied in the multivariate analysis (age>45 years, 2 prior
sternotomies [modified variable], and urgent surgical inter-
vention), the frequency of prolonged PLOS (exceeding 14
days) was 3%, 15%, and 64% in patients with 0, 1, and
more than 1 risk factor, respectively.
DISCUSSION
This is the first large adult series to describe in detail the
in-hospital outcomes in the growing adult population of pa-
tients with repaired TOF undergoing PVR. The mortality
rate is low, and the majority of patients do not have early
postoperative complications. The most common early
events were arrhythmias, respiratory complications, and re-
nal dysfunction. Although most complications will not result
in long-term sequelae, they are associated with prolonged
hospitalization. Patients undergoing urgent interventions,
older patients, and those with multiple previous sternoto-
mies are at the highest risk for prolonged hospitalization.
Although repeat operations for repaired TOF are becom-
ing more common, very little information is available per-
taining to the early postoperative outcomes in this group
of patients. Jacquet and colleagues13 examined the results
of 156 adults with congenital heart disease undergoing car-
diac surgery (repair or reoperation) between 2001 and 2005
in a single institution, which included a subgroup of patients
with TOF (n¼ 33). The Mayo Clinic group19 also examined
the results in a group of 42 patients with repair of TOF (adult
and pediatric) undergoing reoperation between 1974 and
1998. In both series there was 1 early death (3.1% in the se-
ries of Jacquet and colleagues13 and 2% in the series of Dis-
cigil and associates19), which is comparable with results in
our series (2.5%) and lower than in older (operations before
1978) published series.20
The rate of reoperation during the same admission was
higher in our series compared with that seen in the previous
report by Jacquet and colleagues13 (0% vs 14%), and ex-
ploration for bleeding was reported only in 1 (2%) patient
in the Mayo Clinic series (9% in ours). This difference in
reoperation rates between studies might reflect institutional
differences in the management of postoperative bleeding
(6 cases of late cardiac tamponade were reported by Jacquet
and colleagues13) and a different definition of the same out-
come rather than actual different results. Nonetheless, reop-
eration for bleeding had no effect on PLOS in our study.
When compared with postoperative complications in adultsThe Journal of Thoracic and Cundergoing surgical intervention for acquired cardiac dis-
ease, the rate of reoperation for bleeding at the surgical
site is also higher in our series (9% vs 3.1%).21 This differ-
ence in bleeding rate is probably related to the number of
previous operations in our cohort; 58% of our patients
had at least 1 previous surgical palliative procedure, and
20% had 2 or more previous sternotomies.
Arrhythmias were the most frequent complication after
PVR in our cohort. In the smaller series (n ¼ 33) by Jacquet
and colleagues,13 similar rates of early postoperative arrhyth-
mias (18%) were reported. In patients with acquired heart dis-
ease, rates of postoperative arrhythmias can vary between
10% and 65% according to the definition used and the
mode of monitoring.22 The propensity for arrhythmias in
adults with repaired TOF has been well described, and the
stress/hemodynamic changes of surgical intervention likely
precipitate arrhythmias in predisposed subjects. In our series
older patients with a history of arrhythmias were more prone
to postoperative arrhythmias, and particular attention should
be paid to this high-risk group. Whether prophylactic antiar-
rhythmic therapy would be beneficial is yet to be defined.
The rate of myocardial infarction (n ¼ 4, 3%) was high
considering the low atherosclerotic risk profile of our cohort.
Between 2% and 10% of patients with TOF have anoma-
lous coronary arteries crossing the RVOT. Even when iden-
tified preoperatively, the anomalous arteries might pose
problems at the time of intracardiac repair.18 With repeat op-
erations and greater difficulties in the operating field caused
by adhesions and distorted anatomy, these abnormal coro-
nary arteries can be injured. One patient was found to
have a left anterior descending coronary artery compromised
by RVOT running sutures and required urgent reoperation.
Another patient had an anomalous coronary artery crossing
the RVOT that had been identified preoperatively. The un-
derlying mechanism for myocardial ischemia could not be
clarified in 2 patients. Perhaps better preoperative screening
of the coronary anatomy with noninvasive imaging could
guide the surgeon in the operating field to avoid some of
these events.
Although we found that PAEs were relatively common,
most did not result in long-term sequelae. However, the oc-
currence of PAEs is important because they are associated
with prolonged PLOS. PLOS is being increasingly used
for comparisons of surgical outcome between different cen-
ters14-16 as a metric for the complexity of the cases and to
TABLE 4. Multivariate analysis: Predictors of prolonged PLOS
Preoperative factors Odd ratio 95% CI P Value
Age at reoperation>45 y 6.1 1.6–23.6 .009
No. of previous sternotomies 3.8 1.4–10 .007
Urgent operation 5.7 1.1–27.8 .033
Variables entered into the multivariate model included age at reoperation of greater
than 45 years, number of previous sternotomies, urgent operation, and bypass time.
PLOS, Postoperative length of stay; CI, confidence interval.ardiovascular Surgery c Volume 138, Number 3 557
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12% of the patients had a postoperative hospitalization of
longer than 14 days, which is clearly higher than the 5%
published data from the Society of Thoracic Surgeons14
and probably in agreement with the TOF cohort from the
study by Jacquet and colleagues (no data on PLOS>14
days but the same median and interquartile range).13 We
found that patients with prolonged PLOS were more likely
to be older and have an increased number of previous ster-
notomies (more complex surgical cases). Although both of
these variables have been previously shown to be determi-
nants of prolonged PLOS,14 it is important to note that our
cohort is much younger than the previous published cohorts
(mean age, 36 years in our series and 65 years in the Society
of Thoracic Surgeons study14). The rate of previous sternot-
omy is also significantly higher in our study cohort, and this
might, in part, explain the higher rates of prolonged PLOS.
In addition, urgent surgical intervention (unstable patients)
was an independent predictor of PLOS. There are emerging
data suggesting that an earlier indication for PVR might be
important not only in improving right ventricular remodel-
ing23-26 but also in preventing cardiac complications, such
as ventricular tachycardia and right heart failure.27 Although
our results demonstrate a postoperative benefit in patients
who have earlier interventions (younger patients and those
undergoing elective vs urgent surgical intervention), the tim-
ing of PVR remains difficult. The need for subsequent PVR
in these young patients with multiple sternotomies might
become an increasingly difficult problem. A randomized
clinical trial to address the timing of PVR is crucial. In
addition, efforts to improve the longevity of the pulmonary
valve implants to avoid reintervention remain important.
Limitations
This is a retrospective study with its inherent limitations.
Because mortality in this group of patients is low, predictors
of mortality could not be defined. In the future, multicenter
studies might help to answer these questions. Although no
predefined protocol in the postoperative management of
these patients exists in our center, institutional standards of
practice might influence the outcomes. Our center is a tertiary
referral center, and therefore our results might not be able to
be extrapolated to other centers. In addition, most interven-
tions at our center were performed by one surgeon, which
also limits the extrapolation of results to other centers. Fi-
nally, the lack of consensus in the definition of the different
postoperative outcomes makes it difficult to compare results
from different studies. Efforts should be made across centers
to prospectively define outcomes.
CONCLUSIONS
PVR in adults with repaired TOF has a low mortality risk,
and the majority of patients have uncomplicated post-
operative courses. The most common early postoperative558 The Journal of Thoracic and Cardiovascular Sucomplications are arrhythmias and respiratory and renal
complications. Although most early postoperative complica-
tions do not result in long-term sequelae, they are associated
with prolonged hospitalization. Patients undergoing urgent
interventions, older patients, and those with multiple
previous sternotomies are at the highest risk for prolonged
hospitalization.
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211-6.Appendix 1. Definitions
Postoperative death All deaths occurring within the index hospitalization or within 30 days after the surgical procedure
Reoperation Any surgical intervention performed during the same admission and after the index operation, excluding reoperation
caused by defibrillator implantation in patients with inducible ventricular arrhythmias after surgical intervention
Postoperative arrhythmias A spontaneous (not induced in electrophysiologic study) sustained (>30 seconds) or symptomatic arrhythmia
Respiratory complications Prolonged mechanical ventilation (defined as>48 hours17) or respiratory tract infection
Renal dysfunction An increased postoperative creatinine value with a greater than 30% decrease in creatinine clearance calculated by
using the Cockroft–Gault formula below the preoperative value or requiring dialysis
Stroke A new focal neurologic deficit appearing after the surgical operation that persisted at the time of discharge, including
evident deterioration in intellectual function not previously present
Myocardial infarction Persistent ST-segment elevation of greater than 1 mm with evolution to new Q waves postoperatively in 2 or more
contiguous leads
Urgent operation An unplanned operation performed at or after the beginning of the next working day but with the patient kept in the
hospital before the operation
Emergency operation An operation performed immediately on referral to the surgeon or before the beginning of the next working day
Prolonged PLOS A hospital admission time of>14 days14
PLOS, Postoperative length of stay.ardiovascular Surgery c Volume 138, Number 3 559
